[Form 4] TechnipFMC plc Insider Trading Activity

Rhea-AI Filing Summary

TechnipFMC plc (FTI) insider activity: Melin Alf, EVP & Chief Financial Officer, reported multiple transactions on 09/22/2025 executed pursuant to a Rule 10b5-1 trading plan adopted June 23, 2025. The filing shows the exercise/settlement of two employee stock options (6,584 shares at $25.24 and 7,176 shares at $21.10) and the sale of 113,760 ordinary shares in multiple transactions at weighted-average prices of $38.61–$38.62 (with per-trade ranges disclosed). Following these transactions, the reporting person beneficially owned 241,140 shares. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.

Positive

• Transactions executed under a documented Rule 10b5-1 plan, adopted June 23, 2025, which provides an affirmative defense for planned trades.
• Exercise of employee stock options (6,584 shares at $25.24 and 7,176 shares at $21.10), converting derivative awards into ordinary shares before or concurrent with sales.
• Detailed price ranges and weighted-average prices disclosed in footnotes, offering transparency about the multiple sale executions.

Negative

• Significant insider sales on 09/22/2025 totaling 113,760 shares (100,000 + 6,584 + 7,176), which reduced the reporting person’s post-transaction holdings to 241,140 shares.
• Weighted-average sale prices in the high $30s indicate material proceeds but also represent substantial disposition of shares by the CFO on a single day.

Insights

Financial Analyst

TL;DR: Routine option exercises and planned selling under a 10b5-1 plan; transactions do not by themselves indicate a change in company fundamentals.

The filings show exercise of vested employee stock options and concurrent market sales executed under a pre-established Rule 10b5-1 plan adopted on June 23, 2025. Total shares sold on 09/22/2025 were 113,760 at weighted-average prices in the high $30s, while option exercises increased share count before sales. This pattern—exercise followed by sales under a trading plan—is common for executives monetizing compensation and is informational rather than conclusive about firm outlook.

Corporate Governance Expert

TL;DR: Disclosure aligns with typical insider-plan practice; documentation of plan and price ranges adds compliance clarity.

The Form 4 discloses that transactions were effected pursuant to a documented 10b5-1 plan and provides weighted-average sale prices and ranges. The filing also notes anti-dilution adjustments tied to a prior spin-off. The use of an attorney-in-fact signature is permitted and the explanatory footnotes supply required detail for transparency, supporting good disclosure practice.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Melin Alf

(Last) (First) (Middle)

C/O TECHNIPFMC PLC

HADRIAN HOUSE, WINCOMBLEE ROAD

(Street)

NEWCASTLE UPON TYNE X0 NE6 3PL

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TechnipFMC plc [ FTI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	09/22/2025		M		6,584(1)	A	$25.24	347,724	D
Ordinary Shares	09/22/2025		M		7,176(1)	A	$21.1	354,900	D
Ordinary Shares	09/22/2025		S		100,000(1)	D	$38.61(2)	254,900	D
Ordinary Shares	09/22/2025		S		6,584(1)	D	$38.62(3)	248,316	D
Ordinary Shares	09/22/2025		S		7,176(1)	D	$38.62(4)	241,140	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$25.24	09/22/2025		M			6,584(1)(5)	02/26/2021	06/14/2028	Ordinary Shares	6,584	$0	0	D
Employee Stock Option (right to buy)	$21.1	09/22/2025		M			7,176(1)(5)	02/28/2020	06/26/2027	Ordinary Shares	7,176	$0	0	D

Explanation of Responses:

1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 23, 2025.

2. This price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.08 to $38.87 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. This price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.62 to $38.87 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

4. This price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.11 to $38.87 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

5. Reflects the automatic adjustment of the exercise price and number of shares subject to the employee stock option pursuant to anti-dilution provisions contained in the applicable award, which provisions were triggered as a result of the completion of the Issuer's pro-rata distribution of a portion of the outstanding shares of Technip Energies N.V. to the Issuer's shareholders (the "Spin-off") on February 16, 2021.

Remarks:

	/s/ Lisa P. Wang, Attorney-In-Fact	09/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Melin Alf report for TechnipFMC (FTI)?

The Form 4 reports exercise of two employee stock options (6,584 shares at $25.24 and 7,176 shares at $21.10) and sales of 100,000, 6,584 and 7,176 ordinary shares on 09/22/2025.

Were these trades part of a 10b5-1 trading plan for FTI insiders?

Yes. The filing states the transactions were effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 23, 2025.

How many shares did the reporting person own after the reported transactions?

After the reported transactions the reporting person beneficially owned 241,140 ordinary shares.

What prices were the shares sold at in the reported transactions?

The filing discloses weighted-average sale prices: one set at $38.61 (range $38.08–$38.87) and others at $38.62 (ranges disclosed up to $38.87); footnotes provide full per-trade ranges.

Did the Form 4 disclose why option exercise terms changed?

Yes. Footnote 5 explains automatic adjustments to exercise prices and share counts due to anti-dilution provisions triggered by the Issuer’s spin-off distribution on February 16, 2021.

Who signed the Form 4 filing for the reporting person?

The Form 4 was signed by Lisa P. Wang as Attorney-In-Fact on 09/23/2025.